The Victoria’s Secret Global Fund for Women’s Cancers

In Partnership with Pelotonia

2022 Career Development Award applications are now open!

GoApply Now

Tying into its vision to be the world’s leading advocate for women, Victoria's Secret has launched this groundbreaking initiative with longstanding impact partner, Pelotonia, to help combat one of the greatest threats to women’s health worldwide – cancer.

  • This initiative will fund innovative research projects aimed at progressing prevention, detection and treatment methods for women’s cancers and invest in the next generation of female scientists working worldwide.
GoSEE FUNDING OPPORTUNITIES

Tying into its vision to be the world’s leading advocate for women, Victoria's Secret has launched this groundbreaking initiative with longstanding impact partner, Pelotonia, to help combat one of the greatest threats to women’s health worldwide – cancer.

Victoria's Secret Global Fund Awards

GoView the Latest Award Recipients

Why are Pelotonia and Victoria’s Secret launching this initiative?

Victoria’s Secret (VS) has been a truly groundbreaking partner of Pelotonia over the past 13 years, raising more than $20 million from the VS Peloton for cancer research and enabling 100% of every participant-raised dollar to be directed to innovative cancer research through their support as a Major Funding Partner. As VS sought to make a transformational investment in the future of women’s health, they chose Pelotonia as their partner to execute a funding mechanism that will build a global community of cancer advocates and ultimately reduce the cancer burden for women around the world.  

What funding opportunities are currently available?

OPEN - 2022 Career Development Awards - Victoria's Secret will present five female cancer researchers who are in the early stages of their career with this award. The aim of this award is to foster innovation in the understanding, prevention, interception, early detection, diagnosis, and treatment of breast and gynecologic cancers with the goal of eliminating cancer health disparities and improving patient outcomes. The research proposed for funding may be in basic, translational, clinical, or population sciences. The grant provides $206,000 over two years for expenses related to the research project.
NOW CLOSED - View 2022 Meritorious Awardees - Victoria’s Secret will present five female cancer researchers with scientific achievement awards to recognize and further their outstanding contributions to the field of women’s cancers. Each awardee will receive a $100,000 honorarium and will be invited to serve as an active participant and mentor in the broader women’s cancers grant program, which will include multi-year research grants for both established and early-stage investigators. The awards will be presented at the AACR Annual Meeting 2022 in New Orleans. Nominations will be accepted and reviewed by a committee of global cancer research experts overseen by The Fund’s scientific partner, the American Association for Cancer Research (AACR).

How can I learn about future funding opportunities from The Fund?

We will announce additional funding opportunities for mid-level and early-stage female investigators working worldwide to conduct innovative cancer research in the field of women’s cancers in Spring 2022. Please subscribe to our email list here so you don’t miss out on any important updates!

I’m participating in Pelotonia’s annual fundraising campaign as a Rider, Challenger, Volunteer and/or Donor. Will the funds I raise and/or contribute benefit the VS Global Fund for Women’s Cancers? 

The dollars you raise and/or contribute will continue to benefit research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.  

The Victoria’s Secret Global Fund for Women’s Cancers accelerates innovation in cancer research for women, by women.

100% of participant-raised funds go to innovative cancer research.

450 W. Broad Street, Columbus, OH | 614.221.6100

© 2022 Pelotonia. All rights reserved.

Major Funding Partners